Expert: Here’s What to Know About the MPox Outbreak Emergency
Seth Blumberg, MD, PhD, explains the viral disease mpox, and what the recent emergency declaration from the World Health Organization means for us.
![Colorized transmission electron micrograph of mpox virus particles (red) cultivated and purified from cell culture.](/sites/default/files/styles/news_card__image/public/2024-08/mpox.jpg)
University of California San Francisco
Give to UCSFSeth Blumberg, MD, PhD, explains the viral disease mpox, and what the recent emergency declaration from the World Health Organization means for us.
A study determines that a life-saving, inexpensive antibiotic, azithromycin, must be given to all children up to 5 years old in Sub-Sharan Africa to realize its full potential.
Face masks remain crucial in preventing the spread of COVID-19, even with vaccine availability. The decision to wear masks depends on vaccination status, risk factors, and local hospitalizations. Medical N95, KN95, or KF94 masks offer the best protection.
Researchers Micheal Peluso and Valerie Flaherman answer questions about what we know about one of COVID’s most enduring mysteries, including how to potentially reduce your risk and who is most likely to develop long COVID.
Adverse symptoms from the COVID-19 vaccine such as chills and headaches are linked to a robust antibody response, indicating increased efficacy compared with recipients who did not experience side effects.
Liver samples that spent two months in the International Space Station will be studied to observe how microgravity ages liver cells and impacts their ability to regenerate. Understanding how aging damages the liver – and ways to potentially reverse that damage – could pave the way for better prevention and treatment of liver disease.
Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapy, cancer genomics, eliminating treatment disparities and other cancer research topics at this year’s
UCSF scientists have found a set of autoantibodies that emerge in some MS patients years before symptoms.
New CAR-T gene therapy techniques could extend survival for patients with glioblastoma.
Intentional flu vaccine messaging, such as a brief video, flyer, or a scripted provider question, is enough to persuade many who visit emergency departments to receive the vaccination.
The COVID-19 virus can persist in the blood and tissue of patients for more than a year after the acute phase of the illness has ended.
A first of its kind study finds that the COVID vaccine is safe to administer during pregnancy, causing no abnormal delays when the infants were tested at 12 months and again at 18 months.
UCSF will launch the world’s first tissue bank with samples donated by patients with long COVID.
Cancer immunotherapy is hindered by the fact that engineered immune cells often get worn out and depleted before they've killed a tumor. A UCSF team has identified mutations that give cancerous lymphoma T-cells their superpower and transfer those genes into engineered, therapeutic immune cells.
UC San Francisco’s Thomas G. Martin, MD, a leading expert in blood cancers, has received a grant of nearly $4.6 million from the California Institute of Regenerative Medicine (CIRM) to produce a CAR T
The new JN.1 COVID-19 variant is now estimated to make up about 20% of cases in the United States. Three UCSF experts offer advice on vaccines, masking, and other ways to protect yourself.
Fortified stem cells. Enhanced memory. A longevity hormone. UCSF researchers are finding out whether we can cancel – or at least delay – old age.
Thirty-two UCSF scientists are among the most influential individuals in their respective fields, according to the most recent analysis of research citations by the science and intellectual property company, Clarivate.
University of California prostate cancer experts will share clinical insights at the first annual PSMA Conference, “PSMA PET and RLT: Present and Future.” The conference will take place online and in